Company Filing History:
2 out of 33 
1 out of 1 
1 out of 1 
Years Active: 2014-2017
Title: Carole Burel: Innovator in Glycosylated Polypeptide Production
Introduction
Carole Burel is a prominent inventor based in Bourdainville, France. She has made significant contributions to the field of biotechnology, particularly in the production of glycosylated polypeptides. With a total of 2 patents, her work has advanced the understanding and application of genetic engineering in microalgae.
Latest Patents
Carole Burel's latest patents include innovative methods for transforming nucleic acid sequences linked to promoters. One of her patents describes a nucleic acid sequence that encodes an N-acetylglucosaminyltransferase I and/or an α-Mannosidase II, with at least one β-N-acetylglucosaminidase inactivated. This method outlines the steps for producing glycosylated polypeptides by culturing transformed organisms and purifying the expressed polypeptides. Another patent focuses on transformed microalgae capable of expressing glycosylated polypeptides, detailing methods for producing these microalgae and the polypeptides themselves.
Career Highlights
Throughout her career, Carole Burel has worked with esteemed institutions such as the Université de Rouen and L'Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER). Her research has been pivotal in exploring the potential of microalgae in biotechnology applications.
Collaborations
Carole has collaborated with notable colleagues, including Muriel Bardor and Jean-Paul Cadoret. These partnerships have enriched her research and contributed to her innovative work in the field.
Conclusion
Carole Burel's contributions to biotechnology, particularly in the production of glycosylated polypeptides, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing scientific knowledge and applications in this vital area.